Search research articles
Contact Us
Filters
Showing results (201-210 of 488) with videos related to
Page
of 49
Sort By:
Journal of Pediatric Surgery
|
March 19, 2015
Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors
Rodrigo B Interiano, M Beth McCarville, Jianrong Wu, et al.
Journal of Pediatric Surgery
|
January 22, 2013
HIF-1α activation mediates resistance to anti-angiogenic therapy in neuroblastoma xenografts
Joseph Hartwich, W Shannon Orr, Catherine Y Ng, et al.
The Application of Clinical Genetics
|
October 26, 2013
Developments in the treatment of hemophilia B: focus on emerging gene therapy
Maria I Cancio, Ulrike M Reiss, Amit C Nathwani, et al.
Journal of Blood Medicine
|
October 13, 2022
Gene Therapy and Hemophilia: Where Do We Go from Here?
Nancy S Bolous, Nidhi Bhatt, Nickhill Bhakta, et al.
Blood
|
October 18, 2002
Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model
William W Spurbeck, Catherine Y C Ng, Ted S Strom, et al.
BMC Cancer
|
January 27, 2011
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
Amanda Tivnan, Lorraine Tracey, Patrick G Buckley, et al.
Journal of the American College of Surgeons
|
June 26, 2004
Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma
Christian J Streck, Junfang Zhou, Catherine Y Ng, et al.
Plos One
|
August 15, 2017
RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA
Xueling Wu, Jun Yang, Tao Na, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
September 25, 2012
A dedicated automated injection system for dynamic contrast-enhanced MRI experiments in mice
Jan Sedlacik, Adrianne Myers, Ralf B Loeffler, et al.
Surgery
|
July 29, 2008
Bevacizumab suppresses neuroblastoma progression in the setting of minimal disease
Thomas L Sims, Regan F Williams, Cathy Y Ng, et al.
Page
of 49
Search research articles
Search
Showing results (201-210 of 488) with videos related to
Sort By:
Page
of 49
Journal of Pediatric Surgery
|
March 19, 2015
Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors
Rodrigo B Interiano, M Beth McCarville, Jianrong Wu, et al.
Journal of Pediatric Surgery
|
January 22, 2013
HIF-1α activation mediates resistance to anti-angiogenic therapy in neuroblastoma xenografts
Joseph Hartwich, W Shannon Orr, Catherine Y Ng, et al.
The Application of Clinical Genetics
|
October 26, 2013
Developments in the treatment of hemophilia B: focus on emerging gene therapy
Maria I Cancio, Ulrike M Reiss, Amit C Nathwani, et al.
Journal of Blood Medicine
|
October 13, 2022
Gene Therapy and Hemophilia: Where Do We Go from Here?
Nancy S Bolous, Nidhi Bhatt, Nickhill Bhakta, et al.
Blood
|
October 18, 2002
Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model
William W Spurbeck, Catherine Y C Ng, Ted S Strom, et al.
BMC Cancer
|
January 27, 2011
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
Amanda Tivnan, Lorraine Tracey, Patrick G Buckley, et al.
Journal of the American College of Surgeons
|
June 26, 2004
Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma
Christian J Streck, Junfang Zhou, Catherine Y Ng, et al.
Plos One
|
August 15, 2017
RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA
Xueling Wu, Jun Yang, Tao Na, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
September 25, 2012
A dedicated automated injection system for dynamic contrast-enhanced MRI experiments in mice
Jan Sedlacik, Adrianne Myers, Ralf B Loeffler, et al.
Surgery
|
July 29, 2008
Bevacizumab suppresses neuroblastoma progression in the setting of minimal disease
Thomas L Sims, Regan F Williams, Cathy Y Ng, et al.
Page
of 49